AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33407747 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% albumin infusion
Number of subjects: 65
Study 33407747 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride infusion
Number of subjects: 65
Study 32041615 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication skills training program based on the couple focused approach
Number of subjects: 60
Study 32041615 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 35870895 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly physical activity (PA) scheduled
Number of subjects: 134
Study 35870895 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly energisers (short classroom PA breaks) scheduled
Number of subjects: 134
Study 35870895 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed support sustainability strategy - provision of PA equipment packs
Number of subjects: 134
Study 33782701 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-day smartphone ECG monitoring (KardiaMobile)
Number of subjects: 203
Study 33782701 — intervention group
Group type: COMPARATOR
Intervention: 24-h Holter monitoring
Number of subjects: 203
Study 33782701 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-day smartphone ECG monitoring
Number of subjects: 203
Study 32826188 — intervention group
Group type: EXPERIMENTAL
Intervention: MMA injections combined with corticosteroids (ropivacaine, morphine, methylprednisolone)
Number of subjects: 50
Study 32826188 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 50
Study 36123067 — intervention group
Group type: EXPERIMENTAL
Intervention: CytoSorb haemoadsorption along with standard surgical treatment
Number of subjects: 36
Study 36123067 — intervention group
Group type: COMPARATOR
Intervention: Standard surgical treatment alone
Number of subjects: 36
Study 32727624 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 4002
Study 32727624 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Oxygen (HFNO)
Number of subjects: 4002
Study 32727624 — intervention group
Group type: COMPARATOR
Intervention: Standard care (oxygen delivered by face mask or nasal cannula)
Number of subjects: 4002
Study 35874968 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-use App group
Number of subjects: 200
Study 35874968 — intervention group
Group type: COMPARATOR
Intervention: Delayed-use App group
Number of subjects: 200
Study 32891115 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipsilateral tilt position (n = 109)
Number of subjects: 216
Study 32891115 — intervention group
Group type: COMPARATOR
Intervention: Supine position (n = 107)
Number of subjects: 216
Study 34813973 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery rescripting (ImRs)
Number of subjects: 12
Study 34521597 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicycle distribution program
Number of subjects: 525
Study 33616575 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at local acupoints (head, neck)
Number of subjects: 102
Study 33616575 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at distal acupoints (hands, legs, feet)
Number of subjects: 102
Study 33616575 — intervention group
Group type: COMPARATOR
Intervention: Control group (nontreated patients from the waiting list)
Number of subjects: 102
Study 34806246 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT)
Number of subjects: 215
Study 34806246 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive expressive dynamic psychotherapy (SEDP)
Number of subjects: 215
Study 34806246 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 215
Study 33091586 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for insomnia (CBT-I)
Number of subjects: 0
Study 33417476 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon
Number of subjects: 200
Study 33417476 — intervention group
Group type: COMPARATOR
Intervention: Laserballoon
Number of subjects: 200
Study 32380893 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week inter-donation interval
Number of subjects: 20000
Study 32380893 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week inter-donation interval
Number of subjects: 20000
Study 32380893 — intervention group
Group type: EXPERIMENTAL
Intervention: Utility score maximization
Number of subjects: 20000
Study 36167573 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral co-trimoxazole 960 mg once daily for 18 months
Number of subjects: 432
Study 34444682 — intervention group
Group type: EXPERIMENTAL
Intervention: SOFB (sprouted oat fermented beverage)
Number of subjects: 10
Study 34444682 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage (control)
Number of subjects: 10
Study 33108030 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic interval training (AIT) with adherence support, walking/running 4 × 4 minutes at 90% of peak heart rate, 2 days/week for 1 year.
Number of subjects: 48
Study 33108030 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) given 2 introductory AIT sessions and advised to continue training.
Number of subjects: 48
Study 35861446 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous hydration (hypodermoclysis)
Number of subjects: 26
Study 35861446 — intervention group
Group type: COMPARATOR
Intervention: Intravenous hydration
Number of subjects: 26
Study 33389651 — intervention group
Group type: EXPERIMENTAL
Intervention: 153Sm-hydroxyapatite
Number of subjects: 40
Study 33389651 — intervention group
Group type: COMPARATOR
Intervention: 90Y-hydroxyapatite
Number of subjects: 40
Study 32459631 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile-delivered, coach-guided DPP (Noom)
Number of subjects: 202
Study 32459631 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual medical care)
Number of subjects: 202
Study 36305633 — intervention group
Group type: EXPERIMENTAL
Intervention: CJM112 300 mg
Number of subjects: 52
Study 36305633 — intervention group
Group type: EXPERIMENTAL
Intervention: CJM112 75 mg
Number of subjects: 52
Study 36305633 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 33118696 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorb bioresorbable vascular scaffold (BVS)
Number of subjects: 1845
Study 33118696 — intervention group
Group type: COMPARATOR
Intervention: Xience everolimus-eluting stent (EES)
Number of subjects: 1845
Study 32304353 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhong-Yong thinking based DBT group skills training (DBTZYT)
Number of subjects: 97
Study 32304353 — intervention group
Group type: COMPARATOR
Intervention: Supportive group therapy (SGT)
Number of subjects: 97
Study 32304353 — intervention group
Group type: COMPARATOR
Intervention: Wait-list group (WL)
Number of subjects: 97
Study 36241889 — intervention group
Group type: EXPERIMENTAL
Intervention: Moraceae with CHX mouthwash
Number of subjects: 30
Study 36241889 — intervention group
Group type: COMPARATOR
Intervention: CHX-alone mouthwash
Number of subjects: 30
Study 32960145 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous-intensity physical activity (VPA)
Number of subjects: 169
Study 32960145 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate physical activity (MPA)
Number of subjects: 169
Study 32960145 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous-intensity physical activity (VPA) in ≥1-min bouts
Number of subjects: 169
Study 35685760 — intervention group
Group type: EXPERIMENTAL
Intervention: WhatsApp group (n = 41)
Number of subjects: 121
Study 35685760 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic brochures group (n = 41)
Number of subjects: 121
Study 35685760 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 121
Study 35685760 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intervention groups
Number of subjects: 121
Study 35685760 — intervention group
Group type: EXPERIMENTAL
Intervention: WhatsApp group
Number of subjects: 121
Study 34272042 — intervention group
Group type: EXPERIMENTAL
Intervention: IABP support
Number of subjects: 217
Study 34272042 — intervention group
Group type: COMPARATOR
Intervention: No IABP support
Number of subjects: 217
Study 35297108 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination Cal/BD foam (calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g) for 4 weeks
Number of subjects: 0
Study 35297108 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination Cal/BD foam (calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g)
Number of subjects: 0
Study 35297108 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination Cal/BD foam
Number of subjects: 0
Study 36367563 — intervention group
Group type: EXPERIMENTAL
Intervention: Oncokompas
Number of subjects: 58
Study 36367563 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 58
Study 34034339 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated testing in quiet
Number of subjects: 26
Study 34034339 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated testing in noise
Number of subjects: 26
Study 34034339 — intervention group
Group type: COMPARATOR
Intervention: Standard audiometry
Number of subjects: 26
Study 33849632 — intervention group
Group type: EXPERIMENTAL
Intervention: Sharp debridement with needle insertion
Number of subjects: 40
Study 33849632 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological saline water injection
Number of subjects: 40
Study 33849632 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine injection
Number of subjects: 40
Study 33849632 — intervention group
Group type: COMPARATOR
Intervention: Conservative sharp debridement only
Number of subjects: 40
Study 35597698 — intervention group
Group type: EXPERIMENTAL
Intervention: VMAT(vDIBH)
Number of subjects: 21
Study 35597698 — intervention group
Group type: COMPARATOR
Intervention: WT(vDIBH)
Number of subjects: 21
Study 35597698 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 21
Study 32304555 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 insufflation
Number of subjects: 178
Study 32304555 — intervention group
Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 178
Study 35726054 — intervention group
Group type: EXPERIMENTAL
Intervention: N-back working memory training
Number of subjects: 460
Study 35726054 — intervention group
Group type: EXPERIMENTAL
Intervention: Untrained N-back tasks performance
Number of subjects: 460
Study 33152672 — intervention group
Group type: EXPERIMENTAL
Intervention: CTH intervention
Number of subjects: 67
Study 35976752 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative online intervention
Number of subjects: 0
Study 35976752 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-online intervention)
Number of subjects: 0
Study 32812021 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical headgear
Number of subjects: 40
Study 32812021 — intervention group
Group type: COMPARATOR
Intervention: Elastic separators
Number of subjects: 40
Study 34592318 — intervention group
Group type: EXPERIMENTAL
Intervention: tPA bolus (50 mg tPA IV bolus followed by 7 days of heparin)
Number of subjects: 50
Study 34592318 — intervention group
Group type: EXPERIMENTAL
Intervention: tPA drip (50 mg tPA IV bolus, followed by tPA drip 2 mg/h plus heparin 500 units/h over 24 h)
Number of subjects: 50
Study 34592318 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard‐of‐care treatment)
Number of subjects: 50
Study 33038815 — intervention group
Group type: EXPERIMENTAL
Intervention: Momentary assessment (Experience Sampling Method)
Number of subjects: 24
Study 34392331 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril-valsartan
Number of subjects: 731
Study 34392331 — intervention group
Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 731
Study 32276452 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-Activation Performance Enhancement (PAPE)
Number of subjects: 12
Study 32276452 — intervention group
Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 12
Study 35119373 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based data collection (weekly surveys, audio recordings, and passive location data)
Number of subjects: 49
Study 35119373 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based data collection (passively collected location data)
Number of subjects: 49
Study 35119373 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox regression analysis
Number of subjects: 49
Study 35119373 — intervention group
Group type: EXPERIMENTAL
Intervention: Data completeness
Number of subjects: 49
Study 35119373 — intervention group
Group type: EXPERIMENTAL
Intervention: Data completeness over time
Number of subjects: 49
Study 34111416 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronomic capecitabine (650 mg/m2 body surface area twice daily for 1 year)
Number of subjects: 406
Study 34111416 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (observation)
Number of subjects: 406
Study 34111416 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronomic capecitabine
Number of subjects: 406
Study 34111416 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 406
Study 35695863 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib treatment
Number of subjects: 282
Study 35695863 — intervention group
Group type: COMPARATOR
Intervention: Inhibition of β-catenin
Number of subjects: 282
Study 32951870 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional posterior palatal seal
Number of subjects: 0
Study 32951870 — intervention group
Group type: COMPARATOR
Intervention: Arbitrary posterior palatal seal
Number of subjects: 0
Study 36305661 — intervention group
Group type: EXPERIMENTAL
Intervention: Ureteroscopy (URS) for urolithiasis
Number of subjects: 166
Study 33466627 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg of sage combination (CogniviaTM)
Number of subjects: 94
Study 33466627 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 32079999 — intervention group
Group type: EXPERIMENTAL
Intervention: Empathetic interaction
Number of subjects: 68
Study 32079999 — intervention group
Group type: COMPARATOR
Intervention: Neutral interaction
Number of subjects: 68
Study 35608600 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous casirivimab and imdevimab antibody combination
Number of subjects: 0
Study 35608600 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32663179 — intervention group
Group type: EXPERIMENTAL
Intervention: Complementary and integrative medicine
Number of subjects: 556
Study 32663179 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall exercise, massage, and melatonin
Number of subjects: 556
Study 32663179 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective randomized controlled trials
Number of subjects: 556
Study 32663179 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal experience
Number of subjects: 556
Study 35567836 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium dose corticosteroids
Number of subjects: 23
Study 35567836 — intervention group
Group type: COMPARATOR
Intervention: Low dose corticosteroids
Number of subjects: 23
Study 35567836 — intervention group
Group type: COMPARATOR
Intervention: High dose corticosteroids
Number of subjects: 23
Study 35567836 — intervention group
Group type: EXPERIMENTAL
Intervention: All dosing regimens
Number of subjects: 23
Study 34628738 — intervention group
Group type: EXPERIMENTAL
Intervention: ZHU Lian's typeⅡ inhibition acupuncture
Number of subjects: 120
Study 34628738 — intervention group
Group type: COMPARATOR
Intervention: Flunarizine hydrochloride capsule, 5 mg once a day
Number of subjects: 120
Study 32125178 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 U/mL (Gla-300)
Number of subjects: 100
Study 32125178 — intervention group
Group type: COMPARATOR
Intervention: Insulin degludec 100 U/mL (Deg-100)
Number of subjects: 100
Study 32893707 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser with tranexamic acid (TA)
Number of subjects: 30
Study 32893707 — intervention group
Group type: COMPARATOR
Intervention: Microneedling with tranexamic acid (TA)
Number of subjects: 30
Study 34487442 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabinoid-based medicines
Number of subjects: 0
Study 34487442 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36251861 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-body interaction cognitive training (FBI-CT)
Number of subjects: 20
Study 36251861 — intervention group
Group type: COMPARATOR
Intervention: Tablet-based cognitive training (T-CT)
Number of subjects: 20
Study 33671161 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive management
Number of subjects: 98
Study 33671161 — intervention group
Group type: EXPERIMENTAL
Intervention: Sense of cohesion
Number of subjects: 98
Study 33671161 — intervention group
Group type: EXPERIMENTAL
Intervention: Working as a coping strategy
Number of subjects: 98
Study 33671161 — intervention group
Group type: EXPERIMENTAL
Intervention: High demands and lack of acceptance
Number of subjects: 98
Study 36428227 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumac supplementation (500 mg, twice a day for 6 weeks)
Number of subjects: 47
Study 36428227 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose, twice a day for 6 weeks)
Number of subjects: 47
Study 34446475 — intervention group
Group type: EXPERIMENTAL
Intervention: Transient 100% oxygen administration
Number of subjects: 40
Study 34446475 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingestion of a standardised mixed meal
Number of subjects: 40
Study 34446475 — intervention group
Group type: EXPERIMENTAL
Intervention: CBmeter data analysis
Number of subjects: 40
Study 34446475 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 participants)
Number of subjects: 40
Study 32297122 — intervention group
Group type: EXPERIMENTAL
Intervention: Job‐Based Social Skills (JOBSS) curriculum, a manualized, 15‐week, group‐delivered intervention
Number of subjects: 22
Study 32297122 — intervention group
Group type: EXPERIMENTAL
Intervention: Job‐Based Social Skills (JOBSS) curriculum
Number of subjects: 22
Study 32297122 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 22
Study 36098905 — intervention group
Group type: EXPERIMENTAL
Intervention: ClearfilTMS3Bond Plus (CSB)
Number of subjects: 34
Study 36098905 — intervention group
Group type: EXPERIMENTAL
Intervention: ClearfilTMSE Protect Bond (CSEPB)
Number of subjects: 34
Study 36098905 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime&Bond®XP (PBXP)
Number of subjects: 34
Study 33952557 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline (HS) nose drops (2.6% sodium chloride), three drops/nostril, at least four times a day, until 24 hours after asymptomatic or a maximum of 28 days
Number of subjects: 0
Study 33952557 — intervention group
Group type: COMPARATOR
Intervention: Standard symptomatic care
Number of subjects: 0
Study 32683106 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined exercise training (12 weeks, resistance, endurance, Pilates, balance, and stretch exercises, performed 3 days/week)
Number of subjects: 94
Study 32683106 — intervention group
Group type: COMPARATOR
Intervention: Control (waitlist control)
Number of subjects: 94
Study 35042290 — intervention group
Group type: EXPERIMENTAL
Intervention: CT model constructed using radiomic label, pleural depression, and quantitative parameters (diameter, average density)
Number of subjects: 352
Study 35042290 — intervention group
Group type: COMPARATOR
Intervention: Morphological model
Number of subjects: 352
Study 35042290 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive model
Number of subjects: 352
Study 34813369 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh mangos
Number of subjects: 23
Study 34813369 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric low-fat cookies
Number of subjects: 23
Study 34429446 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbial larvicide VectoMax (Bacillus thuringiensis var israelensis and Bacillus sphaericus) applied every 2 weeks in standing water collection points
Number of subjects: 26
Study 34429446 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbial larvicide VectoMax
Number of subjects: 26
Study 34429446 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-intervention area)
Number of subjects: 26
Study 33927333 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body electromyostimulation with exercise training (WB-EMSG)
Number of subjects: 35
Study 33927333 — intervention group
Group type: COMPARATOR
Intervention: Sham control group (ShamG)
Number of subjects: 35
Study 32236442 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise plus nap
Number of subjects: 115
Study 32236442 — intervention group
Group type: COMPARATOR
Intervention: Nap only
Number of subjects: 115
Study 32236442 — intervention group
Group type: COMPARATOR
Intervention: Exercise only
Number of subjects: 115
Study 35616352 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized care (EG)
Number of subjects: 120
Study 35616352 — intervention group
Group type: COMPARATOR
Intervention: Routine care (CG)
Number of subjects: 120
Study 33440330 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic binder placement
Number of subjects: 43
Study 33440330 — intervention group
Group type: COMPARATOR
Intervention: Usual care (non-binder)
Number of subjects: 43
Study 32867226 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic index (LGI) diet plan (n = 40)
Number of subjects: 80
Study 32867226 — intervention group
Group type: COMPARATOR
Intervention: Usual diet (Control group, n = 40)
Number of subjects: 80
Study 35219761 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-insulin treatment
Number of subjects: 0
Study 35219761 — intervention group
Group type: COMPARATOR
Intervention: Insulin treatment
Number of subjects: 0
Study 34777714 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief behavioural intervention for psychological distress
Number of subjects: 410
Study 34777714 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 410
Study 32403259 — intervention group
Group type: EXPERIMENTAL
Intervention: EXP-120 g/h
Number of subjects: 20
Study 32403259 — intervention group
Group type: COMPARATOR
Intervention: CON-90 g/h
Number of subjects: 20
Study 32403259 — intervention group
Group type: COMPARATOR
Intervention: LOW-60 g/h
Number of subjects: 20